Attitudes and Practice of Health Care Providers Toward Cancer Screening: A Cross‑sectional Multicenter Study, Saudi Arabia
As the occupational privilege of health care providers (HCPs) is expected to play a positive role in cancer screening practices, we assessed perceptions and personal attitudes of HCPs regarding their decision to screen for cancer.
NTRK activation in cancer is more than fusions
TRK inhibitors have had some of the most remarkable clinical impacts for patients with tumours driven by oncogenic gene fusions in the TRK genes. But are there other structural variants involving the TRKs that drive cancer? Can these also be targeted by TRK inhibitors?
Soluble Mesothelin and Resistance to Mesothelin Antibody Therapies
Circulating soluble mesothelin can sink antibody-based therapies against tumor expressed mesothelin
Unlocking the power of investigative biopsies in glioma
Glioblastoma (GBM) is a primary brain cancer with a devastating prognosis with limited treatment options. Stereotactic biopsies are performed routinely for histological and molecular diagnosis, but could they also be performed for detailed multi-omics investigation into the tumor microenvironment?
SPECTRUM OF BRAF MUTATIONS IN PAKISTANI COHORT
MOTIVATION BEHIND THE STUDY
"BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort " https://doi.org/10.1186/s12885-024-12925-z
